Cell And Gene Therapy Supply Chain/Logistics Market Report 2026
Cell And Gene Therapy Supply Chain/Logistics Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Cell And Gene Therapy Supply Chain/Logistics Market Report 2026

Global Outlook – By Type Of Software Solution (Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System), By Mode Of Deployment (Cloud-Based Solution, On-Premises Solution), By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cell And Gene Therapy Supply Chain/Logistics Market Overview

• Cell And Gene Therapy Supply Chain/Logistics market size has reached to $1.58 billion in 2025

• Expected to grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%

• Growth Driver: The Surging Demand For Cell And Gene Therapies Reshapes Supply Chain And Logistics

• Market Trend: Advancements In Technology Propel Cell And Gene Therapy Logistics

North America was the largest region and fastest growing region.

What Is Covered Under Cell And Gene Therapy Supply Chain/Logistics Market?

Cell and gene therapy supply chains and logistics refer to the processes and activities involved in efficiently and effectively managing the flow of materials, information, and resources needed to develop, manufacture, and distribute cell and gene therapies from their initial production to their final administration to patients. These services provide cutting-edge treatments to patients while maintaining the highest safety and efficacy standards throughout the supply chain.

The main types of software solutions are cell orchestration platforms, enterprise manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems. A cell orchestration platform refers to a software or technological platform that facilitates the coordination, management, and integration of various processes and activities involved in cell therapy development, manufacturing, and delivery and is used to help streamline and automate tasks related to cell sourcing, manufacturing, quality control, logistics, patient tracking, and data management. They are deployed as a cloud-based solution; an on-premises solution in cryogenic shippers; cryogenic storage freezers; ultra-low freezers; cold chain management systems; shipment; storage medium; cryogenic packout kits; and other components. These solutions are used in applications such as donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up by end users including biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

Cell And Gene Therapy Supply Chain/Logistics Market Global Report 2026 Market Report bar graph

What Is The Cell And Gene Therapy Supply Chain/Logistics Market Size and Share 2026?

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.58 billion in 2025 to $1.78 billion in 2026 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing complexity of cell and gene therapy logistics, early adoption of cryogenic shipping solutions, expansion of centralized manufacturing models, growing regulatory focus on traceability, rising use of specialized logistics providers.

What Is The Cell And Gene Therapy Supply Chain/Logistics Market Growth Forecast?

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.81 billion in 2030 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to increasing commercialization of personalized therapies, rising demand for end-to-end supply chain visibility, expansion of global therapy distribution networks, growing adoption of cloud-based logistics platforms, increasing investments in smart cold chain infrastructure. Major trends in the forecast period include expansion of integrated cold chain management platforms, growing adoption of real-time tracking and traceability systems, rising use of cryogenic logistics solutions, increasing integration of patient-centric supply chain models, enhanced focus on chain of custody compliance.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System

2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution

3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components

4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up

5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

Subsegments:

1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools

2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)

3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization

4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting

5) By Logistics Management System: Route Optimization And Planning, Transportation Management

6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes

7) By Quality Management System: Compliance Tracking, Quality Assurance And Control

8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation

What Is The Driver Of The Cell And Gene Therapy Supply Chain/Logistics Market?

The increasing need for cell and gene therapies is driving the cell and gene therapy supply chain or logistics market. Cell and gene therapies are advanced medical treatments that modify cells or genes to treat diseases, offering potential breakthroughs for untreatable conditions. These cell and gene therapies need to be stored at the proper temperature and storage conditions, which can be achieved using supply chain and logistics services, which help from sourcing to distributing and storing these cell and gene therapies. For instance, in 2023, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase since Q3 2022. Therefore, the increasing need for cell and gene therapies drives the cell and gene therapy supply chain or logistics market forward.

Key Players In The Global Cell And Gene Therapy Supply Chain/Logistics Market

Major companies operating in the cell and gene therapy supply chain/logistics market are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

Global Cell And Gene Therapy Supply Chain/Logistics Market Trends and Insights

Modern technology platforms are a key trend gaining popularity in the cell and gene therapy supply chain/logistics markets. Major companies operating in the market are developing modern technology platforms for cell and gene therapies to sustain their position in the market. For instance, in April 2023, AmerisourceBergen Corporation., a US-based healthcare company specializing in cell and gene therapy supply chain logistics, launched the Cell and Gene Therapy (CGT) Integration Hub. The Cell and Gene Therapy (CGT) Integration Hub is powered by AmerisourceBergen’s innovative customer relationship management (CRM) system. It can be integrated into the biopharma platform to facilitate better monitoring of the development and delivery of cell and gene therapies.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market?

In October 2025, Peli BioThermal, a US-based provider of temperature-controlled packaging solutions, acquired EVO, for an undisclosed amount. With this acquisition, Peli BioThermal aims to expand its cold chain capabilities, enhance service offerings for temperature-sensitive shipments, strengthen its global logistics network, and support growth in life sciences and healthcare markets. EVO is a US-based cold chain company, that offers cell and gene therapy supply chain or logistics.

Regional Outlook

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell And Gene Therapy Supply Chain/Logistics Market?

The cell and gene therapy supply chain and logistics market includes revenues earned by entities by providing sourcing and collection, quality testing, distribution, and transportation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell And Gene Therapy Supply Chain/Logistics Market Report 2026?

The cell and gene therapy supply chain/logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy supply chain/logistics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Cell And Gene Therapy Supply Chain/Logistics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.78 billion
Revenue Forecast In 2035 $2.81 billion
Growth Rate CAGR of 12.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type Of Software Solution, Mode Of Deployment, Component, Application Area, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Cell And Gene Therapy Supply Chain/Logistics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Cell And Gene Therapy Supply Chain/Logistics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Expansion Of Integrated Cold Chain Management Platforms

4.2.2 Growing Adoption Of Real-Time Tracking And Traceability Systems

4.2.3 Rising Use Of Cryogenic Logistics Solutions

4.2.4 Increasing Integration Of Patient-Centric Supply Chain Models

4.2.5 Enhanced Focus On Chain Of Custody Compliance

5. Cell And Gene Therapy Supply Chain/Logistics Market Analysis Of End Use Industries

5.1 Biobanks

5.2 Cell Therapy Laboratories

5.3 Hospitals

5.4 Research Institutes

5.5 Commercial Therapy Providers

6. Cell And Gene Therapy Supply Chain/Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cell And Gene Therapy Supply Chain/Logistics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Cell And Gene Therapy Supply Chain/Logistics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Cell And Gene Therapy Supply Chain/Logistics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cell And Gene Therapy Supply Chain/Logistics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

9.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System

9.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cloud-Based Solution, On-Premises Solution

9.3. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components

9.4. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up

9.5. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

9.6. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Workflow Management, Scheduling And Coordination Tools

9.7. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Production Planning And Control, Manufacturing Execution Systems (MES)

9.8. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stock Tracking And Management, Inventory Forecasting And Optimization

9.9. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sample Tracking And Management, Data Management And Reporting

9.10. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Route Optimization And Planning, Transportation Management

9.11. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes

9.12. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Compliance Tracking, Quality Assurance And Control

9.13. Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Real-Time Tracking Of Shipments, Chain Of Custody Documentation

10. Cell And Gene Therapy Supply Chain/Logistics Market Regional And Country Analysis

10.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market

11.1. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cell And Gene Therapy Supply Chain/Logistics Market

12.1. China Cell And Gene Therapy Supply Chain/Logistics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cell And Gene Therapy Supply Chain/Logistics Market

13.1. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cell And Gene Therapy Supply Chain/Logistics Market

14.1. Japan Cell And Gene Therapy Supply Chain/Logistics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cell And Gene Therapy Supply Chain/Logistics Market

15.1. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market

16.1. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cell And Gene Therapy Supply Chain/Logistics Market

17.1. South Korea Cell And Gene Therapy Supply Chain/Logistics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cell And Gene Therapy Supply Chain/Logistics Market

18.1. Taiwan Cell And Gene Therapy Supply Chain/Logistics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cell And Gene Therapy Supply Chain/Logistics Market

19.1. South East Asia Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market

20.1. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cell And Gene Therapy Supply Chain/Logistics Market

21.1. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cell And Gene Therapy Supply Chain/Logistics Market

22.1. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cell And Gene Therapy Supply Chain/Logistics Market

23.1. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cell And Gene Therapy Supply Chain/Logistics Market

24.1. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cell And Gene Therapy Supply Chain/Logistics Market

25.1. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market

26.1. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cell And Gene Therapy Supply Chain/Logistics Market

27.1. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cell And Gene Therapy Supply Chain/Logistics Market

28.1. North America Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cell And Gene Therapy Supply Chain/Logistics Market

29.1. USA Cell And Gene Therapy Supply Chain/Logistics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cell And Gene Therapy Supply Chain/Logistics Market

30.1. Canada Cell And Gene Therapy Supply Chain/Logistics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cell And Gene Therapy Supply Chain/Logistics Market

31.1. South America Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cell And Gene Therapy Supply Chain/Logistics Market

32.1. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cell And Gene Therapy Supply Chain/Logistics Market

33.1. Middle East Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cell And Gene Therapy Supply Chain/Logistics Market

34.1. Africa Cell And Gene Therapy Supply Chain/Logistics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Segmentation By Mode Of Deployment, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cell And Gene Therapy Supply Chain/Logistics Market Regulatory and Investment Landscape

36. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Company Profiles

36.1. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Cell And Gene Therapy Supply Chain/Logistics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Cell And Gene Therapy Supply Chain/Logistics Market Company Profiles

36.3.1. AmerisourceBergen Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.2. United Parcel Service Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Avantor Sciences Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

37. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies

Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc.

38. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market

40. Cell And Gene Therapy Supply Chain/Logistics Market High Potential Countries, Segments and Strategies

40.1 Cell And Gene Therapy Supply Chain/Logistics Market In 2030 - Countries Offering Most New Opportunities

40.2 Cell And Gene Therapy Supply Chain/Logistics Market In 2030 - Segments Offering Most New Opportunities

40.3 Cell And Gene Therapy Supply Chain/Logistics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Cell And Gene Therapy Supply Chain/Logistics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Cell And Gene Therapy Supply Chain/Logistics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Supply Chain Analysis
  • Table 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Raw Material Providers
  • Table 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Resource Providers
  • Table 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Distributors And Channel Partners
  • Table 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Key Technologies & Future Trends
  • Table 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Trends
  • Table 10: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major End Users
  • Table 11: Global Cell And Gene Therapy Supply Chain/Logistics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Cell And Gene Therapy Supply Chain/Logistics Market - TAM, US$ Billion, 2025
  • Table 15: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Taiwan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Taiwan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Taiwan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: South East Asia , Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: South East Asia , Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: South East Asia , Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 100: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 101: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 102: Global Cell And Gene Therapy Supply Chain/Logistics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 103: Global Cell And Gene Therapy Supply Chain/Logistics Market - Company Scoring Matrix
  • Table 104: AmerisourceBergen Corporation Financial Performance
  • Table 105: United Parcel Service Financial Performance
  • Table 106: Thermo Fisher Scientific Inc. Financial Performance
  • Table 107: Avantor Sciences Financial Performance
  • Table 108: Lonza Group AG Financial Performance
  • Table 109: Global Cell And Gene Therapy Supply Chain/Logistics Market, Competitive Benchmarking (In USD Billions)
  • Table 110: Global Cell And Gene Therapy Supply Chain/Logistics Market, Competitive Dashboard
  • Table 111: Global Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 112: Global, Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), Segmentation By Type Of Software Solution, 2025 – 2030
  • Table 113: Global, Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), Segmentation By Mode Of Deployment, 2025 – 2030
  • Table 114: Global, Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030

List Of Figures

    Figure 1: Global Cell And Gene Therapy Supply Chain/Logistics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Cell And Gene Therapy Supply Chain/Logistics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Cell And Gene Therapy Supply Chain/Logistics Market, Supply Chain Analysis
  • Figure 4: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Raw Material Providers
  • Figure 5: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Resource Providers
  • Figure 6: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Distributors And Channel Partners
  • Figure 8: Global Cell And Gene Therapy Supply Chain/Logistics Market, Key Technologies & Future Trends
  • Figure 9: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major Trends
  • Figure 10: Global Cell And Gene Therapy Supply Chain/Logistics Market, Major End Users
  • Figure 11: Global Cell And Gene Therapy Supply Chain/Logistics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Cell And Gene Therapy Supply Chain/Logistics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Cell Orchestration Platform, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Enterprise Manufacturing System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Inventory Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Laboratory Information Management System (LIMS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Logistics Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Patient Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Quality Management System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Global Cell And Gene Therapy Supply Chain/Logistics Market, Sub-Segmentation Of Tracking And Tracing System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Asia-Pacific, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: China, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: India, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Japan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Australia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Indonesia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South Korea, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Taiwan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Taiwan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Taiwan, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: South East Asia , Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: South East Asia , Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: South East Asia , Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Western Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: UK, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Germany, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: France, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Italy, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Spain, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Eastern Europe, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Russia, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: North America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: USA, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Canada, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: South America, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Brazil, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Middle East, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 100: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 101: Africa, Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 102: Global Cell And Gene Therapy Supply Chain/Logistics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 103: Global Cell And Gene Therapy Supply Chain/Logistics Market - Company Scoring Matrix
  • Figure 104: AmerisourceBergen Corporation Financial Performance
  • Figure 105: United Parcel Service Financial Performance
  • Figure 106: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 107: Avantor Sciences Financial Performance
  • Figure 108: Lonza Group AG Financial Performance
  • Figure 109: Global Cell And Gene Therapy Supply Chain/Logistics Market, Competitive Benchmarking (In USD Billions)
  • Figure 110: Global Cell And Gene Therapy Supply Chain/Logistics Market, Competitive Dashboard
  • Figure 111: Global Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 112: Global, Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), Segmentation By Type Of Software Solution, 2025 – 2030
  • Figure 113: Global, Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), Segmentation By Mode Of Deployment, 2025 – 2030
  • Figure 114: Global, Cell And Gene Therapy Supply Chain/Logistics Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030

Frequently Asked Questions

The Cell And Gene Therapy Supply Chain/Logistics market was valued at $1.58 billion in 2025, increased to $1.78 billion in 2026, and is projected to reach $2.81 billion by 2030.

The global Cell And Gene Therapy Supply Chain/Logistics market is expected to grow at a CAGR of 12.1% from 2026 to 2035 to reach $2.81 billion by 2035.

Some Key Players in the Cell And Gene Therapy Supply Chain/Logistics market Include, AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Labo

Major trend in this market includes: Advancements In Technology Propel Cell And Gene Therapy Logistics. For further insights on this market. request a sample here

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2025. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, South East Asia, Western Europe, Easter

Customer representative image Book your 30 minutes free consultation with our research experts